↓ Skip to main content

Interleukin 3 is a growth factor for human follicular B cell lymphoma.

Overview of attention for article published in The Journal of Experimental Medicine, February 1992
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
9 patents

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Interleukin 3 is a growth factor for human follicular B cell lymphoma.
Published in
The Journal of Experimental Medicine, February 1992
DOI 10.1084/jem.175.2.371
Pubmed ID
Authors
Abstract

More than one-half of adults with non-Hodgkin's B cell lymphomas present with low-grade follicular lymphomas. These tumor cells are found in close association with follicular T lymphocytes and dendritic cells, suggesting that the surrounding cells may play a role in the support of follicular tumors. Supernatants from activated human peripheral blood lymphocytes were found to promote the in vitro proliferation of follicular tumor cells. This effect was entirely due to interleukin 3 (IL-3), a factor generally thought to cause the growth and differentiation of immature hematopoietic cells. IL-3 receptors were detected on fresh isolates of all primary follicular cell tumors examined. These findings suggest that follicular cell tumors may be dependent in vivo on IL-3 and that therapies directed against IL-3, its receptor, or the T cells that produce it may be effective treatment for follicular lymphoma.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 3 27%
Professor 2 18%
Other 1 9%
Student > Bachelor 1 9%
Student > Master 1 9%
Other 1 9%
Unknown 2 18%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 5 45%
Medicine and Dentistry 2 18%
Environmental Science 1 9%
Unknown 3 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2025.
All research outputs
#7,582,289
of 34,363,559 outputs
Outputs from The Journal of Experimental Medicine
#6,126
of 13,367 outputs
Outputs of similar age
#9,589
of 89,306 outputs
Outputs of similar age from The Journal of Experimental Medicine
#26
of 74 outputs
Altmetric has tracked 34,363,559 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 13,367 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.3. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 89,306 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.